Vir Biotechnology (VIR) Non-cash Items (2019 - 2022)

Vir Biotechnology's Non-cash Items history spans 4 years, with the latest figure at $52.3 million for Q4 2022.

  • On a quarterly basis, Non-cash Items fell 70.35% to $52.3 million in Q4 2022 year-over-year; TTM through Dec 2022 was $52.3 million, a 70.35% decrease, with the full-year FY2022 number at $52.3 million, down 70.35% from a year prior.
  • Non-cash Items hit $52.3 million in Q4 2022 for Vir Biotechnology, down from $65.5 million in the prior quarter.
  • Over the last five years, Non-cash Items for VIR hit a ceiling of $250.2 million in Q2 2020 and a floor of $25.1 million in Q4 2019.
  • Historically, Non-cash Items has averaged $145.0 million across 4 years, with a median of $147.0 million in 2020.
  • Biggest five-year swings in Non-cash Items: skyrocketed 368.13% in 2020 and later tumbled 70.35% in 2022.
  • Tracing VIR's Non-cash Items over 4 years: stood at $25.1 million in 2019, then skyrocketed by 368.13% to $117.5 million in 2020, then skyrocketed by 50.13% to $176.4 million in 2021, then tumbled by 70.35% to $52.3 million in 2022.
  • Business Quant data shows Non-cash Items for VIR at $52.3 million in Q4 2022, $65.5 million in Q1 2022, and $176.4 million in Q4 2021.